Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo
Company states the realisation of generic competition is neither certain nor imminent
15-Nov-2007 -
Orion Corporation has filed a patent infringement lawsuit in the United States to enforce its formulation patent, U.S. Patent No. 6,500,867, against Sun Pharmaceutical Industries Inc. and Sun Pharmaceutical Industries Limited, who seek to market generic versions of Stalevo® tablets (25/100/200 ...
Novartis
Parkinson's disease
patent infringement